A complete spectrum of advanced cardiac imaging and preventive cardiology — engineered around earlier detection, sharper decisions, and personalized outcomes.
Cardiac CT is now the most powerful non-invasive way to evaluate coronary anatomy, structure, and disease — with sub-millimeter resolution and minutes-long acquisition.
Patients with chest pain, established risk factors, or unexplained symptoms — and physicians seeking definitive answers without catheterization.
Definitive rule-in or rule-out of coronary disease, with the anatomy and biology needed to guide every next step.
Coronary CTA has become a first-line test for stable chest pain — combining diagnostic accuracy with prognostic insight beyond stress testing alone.
Symptomatic patients across the risk spectrum, including those previously labeled 'low-yield' for invasive workup.
More appropriate downstream testing, fewer unnecessary catheterizations, and a clearer view of true coronary disease.
Stenosis tells only part of the story. Plaque composition, burden, and distribution define cardiovascular biology and predict events.
Patients seeking precision risk refinement, and physicians planning personalized prevention or revascularization strategies.
Therapy intensified, de-escalated, or personalized based on the true biology of disease — not population averages.
FFR-CT brings hemodynamic significance into the same study as anatomy — eliminating the need for many invasive functional assessments.
Patients with intermediate-grade coronary lesions where physiology drives management.
Reduces invasive procedures while preserving — and often improving — diagnostic certainty.
Cardiovascular disease is fundamentally metabolic. True prevention requires integrating lipids, glycemic health, vascular imaging, and behavior.
Patients at any stage of the cardiovascular continuum — from primary prevention through post-event optimization.
Long-term risk reduction through individualized, evidence-based metabolic and vascular optimization.
Cardiac MRI provides unmatched tissue characterization — essential for cardiomyopathies, viability assessment, and inflammatory disease.
Patients with unexplained heart failure, suspected infiltrative disease, or post-infarct evaluation.
A complete cardiovascular phenotype that complements anatomy with biology and function.
Modern CT enables pre-procedural mapping of complex coronary anatomy — turning challenging interventions into planned, predictable procedures.
Interventional teams and patients facing CTO or otherwise complex revascularization decisions.
Higher procedural success, shorter case times, and better-informed patient conversations.
Calcium scoring and CTA dramatically refine cardiovascular risk beyond traditional calculators — often changing the management of borderline cases.
Patients in the intermediate-risk zone where therapeutic decisions hinge on more information.
Right therapy, right intensity, right patient — driven by imaging rather than estimation.
Imaging-informed prevention transforms cardiology from reactive to proactive — identifying disease in time to change its trajectory.
Adults seeking the most rigorous, personalized assessment of their cardiovascular future.
Years of disease modification — not just decades of guesswork.
Direct physician-to-physician collaboration and patient referrals are welcome.